Researchers have engineered Lyme bacterial protein, CspZ, to produce a robust immune response in mice for vaccine development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback